查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1901547

核酸扩增检测市场：按类型、应用、最终用途、国家和地区划分 - 全球产业分析、市场规模、市场份额及2024-2032年预测

Nucleic Acid Amplification Testing Market, By Type, By Application, By End-use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 399 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年核酸扩增检测市场规模为 98.9745 亿美元，从 2025 年到 2032 年将以 9.5% 的复合年增长率成长。

核酸扩增检测（NAAT）市场正经历强劲的全球成长，这主要得益于全球传染病流行率的上升以及分子诊断技术的不断进步。 NAAT 是一种高灵敏度技术，是检测和定量核酸（DNA 或 RNA）的黄金标准，在诊断 COVID-19、HIV 和结核病等疾病方面至关重要。对快速、分散式即时检测（POC​​）日益增长的需求，以及 NAAT 在肿瘤学和个人化医疗领域应用的不断扩展，是推动市场扩张的关键因素。

核酸扩增检测市场—市场动态

传染病和公共卫生危机日益增多

包括呼吸道感染、性传染感染（STI）以及新兴或再发病原体在内的传染病日益流行，为全球公共卫生系统带来了严峻挑战，而全球化、都市化和气候变迁等因素加剧了这一趋势。例如，根据世界卫生组织（世卫组织）统计，2023年全球约有1,080万人患有结核病（TB），其中包括600万男性、360万名女性和130万名儿童。为此，核酸扩增检测（NAAT）的应用变得至关重要，这主要归功于其高灵敏度和特异性，即使在症状出现之前也能早期发现感染。早期识别有助于及时治疗，有效降低不良健康后果和传播率，尤其是在性传染感染方面。此外，NAAT在公共卫生监测中也发挥关键作用，能够在疫情爆发期间进行快速检测，有助于控制疾病传播。其检测新病原体的适应性对于应对公共卫生突发事件至关重要，凸显了将 NAAT 纳入常规卫生策略的必要性，以加强应对传染病的准备和资源分配。

核酸扩增检测市场区隔分析：

全球核酸扩增检测市场按类型、应用、最终用途和地区进行细分。

根据类型，市场可分为聚合酶炼式反应 (PCR) 检测、等温核酸扩增技术 (INAAT) 检测和其他检测。 PCR 检测因其高灵敏度、多功能性以及在诊断和研究应用中的广泛使用而占据最大市场份额，而 INAAT 检测则因其快速处理和适用于即时检测而日益受到关注。

根据应用领域，市场可分为传染病检测、肿瘤检测、遗传及粒线体疾病检测和其他应用。由于病毒和细菌感染的日益普及、对精准诊断解决方案的需求不断增长以及分子检测在临床实验室的广泛应用，传染病检测占据了最大的市场份额。

根据最终用途，市场可分为中心实验室和参考实验室、即时检测机构、生物技术和製药公司、学术和研究机构以及其他机构。中心实验室和参考实验室凭藉其广泛的检测服务以及对诊断准确性和可靠性的承诺，占据了相当大的市场份额。随着对能够促进快速临床决策的即时诊断解决方案的需求不断增长，尤其是在急诊和偏远地区的医疗环境中，即时检测机构正经历快速成长。

核酸扩增检测市场—地域洞察

核酸扩增检测市场主要由北美地区驱动，该地区凭藉先进的医疗基础设施、大量的研发投入以及高传染病发病率，占据了最大的市场份额。紧随其后的是亚太地区，该地区正经历着显着增长，这主要得益于不断增长的医疗支出、对精准诊断解决方案日益增长的需求以及不断扩大的人口及其面临的各种健康挑战。欧洲则位居第三，受益于其完善的医疗体系和对分子诊断的强而有力的监管支持。拉丁美洲（LATAM）也在成长，儘管成长较慢，但医疗服务可及性的提高和传染病意识的增强推动了市场的扩张。最后，中东和非洲（MEA）地区面临医疗资源有限等挑战，但改善医疗基础设施和提高疾病意识的努力正在逐步促进市场成长。整体而言，全球市场分布反映了不同地区医疗成熟度和诊断技术投资水准的差异。

核酸扩增检测市场—国家概况

美国是核酸扩增检测 (NAAT) 的主导市场，这主要得益于其先进的医疗保健基础设施、大量的研发投入以及高传染病发病率。精准快速诊断解决方案的需求推动了 NAAT 在临床实验室、医院和即时检测机构的广泛应用。此外，美国拥有健全的监管框架，为创新诊断技术的发展提供了支持。其他值得关注的市场包括加拿大和墨西哥，这两个市场也因医疗保健支出增加和分子诊断意识的提高而呈现成长态势，共同构成了北美市场的蓬勃发展。

目录

第一章：核酸扩增检测市场概览

  • 研究范围
  • 市场估算年份

第二章：执行概要

  • 市集
  • 竞争洞察

第三章：核酸扩增检测主要市场趋势

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 市场未来趋势

第四章：核酸扩增检测产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景分析
  • 规范架构分析

第五章：核酸扩增检验市场：地缘政治紧张局势升级的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：核酸扩增检测市场概况

  • 核酸扩增检测市占率分析，2024年
  • 主要製造商细分数据
    • 知名球员分析
    • 新兴参与者分析

第七章：核酸扩增检验市场：依类型划分

  • 概述
    • 细分市场占有率分析：按类型
    • 聚合酶炼式反应（PCR）检测
    • 等温核酸扩增技术（INAAT）检测
    • 其他的

第八章：核酸扩增检测市场：依应用领域划分

  • 概述
    • 细分市场占有率分析：按应用
    • 传染病检测
    • 肿瘤检测
    • 基因和粒线体疾病检测
    • 其他的

第九章：核酸扩增检验市场：依最终用途划分

  • 概述
    • 细分市场占有率分析：依最终用途
    • 传染病检测
    • 肿瘤检测
    • 基因和粒线体疾病检测
    • 其他的

第十章：核酸扩增检验市场：依地域划分

  • 介绍
  • 北美洲
    • 概述
    • 北美主要製造商
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • その他
  • 亚太地区
    • 概述
    • 亚太地区主要製造商
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • その他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • その他
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲的主要製造商
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • その他

第十一章：主要供应商分析：核酸扩增检测产业

  • 竞争格局分析
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Roche (F. Hoffmann-La Roche Ltd.)
    • Abbott Laboratories
    • Thermo Fisher Scientific Inc.
    • bioMerieux
    • Hologic
    • QIAGEN
    • Bio-Rad Laboratories
    • Danaher
    • Grifols SA
    • Seegene Inc.
    • Others

第12章：全面展望

简介目录
Product Code: ANV5866

The Nucleic Acid Amplification testing Market size was valued at US$9,897.45 Million in 2024, expanding at a CAGR of 9.5% from 2025 to 2032.

The Nucleic Acid Amplification Testing market is experiencing robust global growth driven by the rising prevalence of infectious diseases worldwide and continuous technological advancements in molecular diagnostics. NAAT, a highly sensitive technique, is the gold standard for detecting and quantifying nucleic acids (DNA or RNA) and is vital in diagnosing conditions such as COVID-19, HIV, and Tuberculosis. The growing demand for rapid, decentralized Point-of-Care (POC) testing and the increasing application of NAAT in oncology and personalized medicine are key factors propelling market expansion.

Nucleic Acid Amplification testing Market- Market Dynamics

Rising Prevalence of Infectious Diseases and Public Health Crises

The rising prevalence of infectious diseases, including respiratory infections, sexually transmitted infections (STIs), and newly emerging or re-emerging pathogens, presents significant challenges for global public health systems, driven by factors such as globalization, urbanization, and climate change, For instance, according to the World Health Organization (WHO), approximately 10.8 million people were reported to have fallen ill with Tuberculosis (TB) globally in 2023, encompassing 6.0 million men, 3.6 million women, and 1.3 million children . In response, the adoption of Nucleic Acid Amplification Tests (NAAT) has become essential, primarily due to its high sensitivity and specificity, which facilitate early detection of infections even before symptoms appear. This early identification enables timely treatment, effectively minimizing adverse health outcomes and transmission rates, especially in the case of STIs. Moreover, NAAT plays a crucial role in public health surveillance, allowing for rapid testing during outbreaks and thereby aiding in the control of disease spread. Its adaptability to detect new pathogens is vital for responding to public health emergencies, underscoring the need for integrating NAAT into routine health strategies to enhance preparedness and resource allocation in combating infectious diseases.

Nucleic Acid Amplification testing Market- Segmentation Analysis:

The Global Nucleic Acid Amplification testing Market is segmented on the basis of Type, Application, End-use, and Region.

Based on Type, the market is divided into Polymerase Chain Reaction (PCR) Tests, Isothermal Nucleic Acid Amplification Technology (INAAT) Tests, and Others. PCR tests hold the largest share due to their high sensitivity, versatility, and widespread use in diagnostic and research applications, while INAAT tests are gaining traction for their rapid processing and suitability for point-of-care testing.

Based on Application, the market is divided into Infectious Disease Testing, Oncology Testing, Genetic & Mitochondrial Disease Testing, and Other Applications. Infectious disease testing accounts for the largest market share due to the rising prevalence of viral and bacterial infections, increasing demand for accurate diagnostic solutions, and widespread adoption of molecular testing in clinical laboratories.

Based on end use the market is divided into Central and Reference Laboratories, Point-of-Care Settings, Biotechnology & Pharmaceutical Companies, and Academic & Research Institutes and others. Central and reference laboratories account for a significant share due to their extensive testing services and commitment to accuracy and reliability in diagnostics. Point-of-care settings are experiencing rapid growth as demand increases for immediate diagnostic solutions that facilitate prompt clinical decision-making, particularly in urgent and remote care environments.

Nucleic Acid Amplification testing Market- Geographical Insights

The Nucleic Acid Amplification Testing market is predominantly driven by North America, which holds the largest share due to advanced healthcare infrastructure, significant investment in research and development, and a high prevalence of infectious diseases. Following North America, the Asia Pacific region is experiencing substantial growth, propelled by rising healthcare expenditures, increasing demand for accurate diagnostic solutions, and a growing population with diverse health challenges. Europe ranks next, benefiting from robust healthcare systems and strong regulatory support for molecular diagnostics. Latin America (LATAM) is also witnessing growth, although at a slower pace, as improvements in healthcare access and rising awareness of infectious diseases contribute to the market's expansion. Lastly, the Middle East and Africa (MEA) region faces challenges such as limited healthcare resources, but efforts to enhance healthcare infrastructure and increasing disease awareness are gradually fostering market growth. Overall, the global distribution reflects varying levels of healthcare maturity and investment in diagnostic technologies.

Nucleic Acid Amplification testing Market- Country Insights

The United States is the dominant market for Nucleic Acid Amplification Testing (NAAT), driven by its advanced healthcare infrastructure, significant investment in research and development, and a high incidence of infectious diseases. The demand for accurate and rapid diagnostic solutions has fostered widespread adoption of NAAT across clinical laboratories, hospitals, and point-of-care settings. Additionally, the U.S. benefits from a strong regulatory framework that supports innovative diagnostic technologies. Other notable markets include Canada and Mexico, which are also experiencing growth due to increasing healthcare expenditures and rising awareness of molecular diagnostics, contributing to a robust North American market landscape.

Nucleic Acid Amplification testing Market- Competitive Landscape:

The Nucleic Acid Amplification Testing (NAAT) market is highly competitive, featuring key players like Roche, Abbott Laboratories, and Thermo Fisher Scientific, known for their innovative diagnostic solutions and extensive product portfolios. bioMerieux and Hologic focus on infectious disease testing, enhancing their market presence through advanced technologies and strategic partnerships. QIAGEN and Bio-Rad Laboratories emphasize assay development and molecular diagnostics, while Danaher leverages its strong R&D capabilities to drive growth. Grifols S.A. and Seegene Inc. are also making strides in the market, contributing unique technologies and expanding their geographical reach, thereby intensifying competition and fostering innovation in NAAT applications. These companies emphasize technological innovation, expansion of product portfolios, and strategic partnerships to enhance their global footprint. For instance, In July 2025, South Korea-based Seegene Inc. launched its CURECA fully automated PCR testing system alongside its STAgora data analytics platform. CURECA is notable as the world's first system to completely automate the entire PCR testing process, which includes everything from sample storage and pre-treatment to nucleic acid extraction, amplification, and final result analysis, requiring no human intervention. Seegene states that the introduction of these new technologies represents a transformative shift in the global diagnostics paradigm.

Recent Developments:

In September 2024 Takara Bio USA, Inc. introduced the SmartChip ND Real-Time PCR System, an automated, high-throughput quantitative PCR (qPCR) solution designated for research-use-only (RUO). This system is designed specifically for monitoring antimicrobial resistance (AMR), addressing the increasing global need for advanced tools in environmental safety and sustainability research.

In December 2025 Roche introduced the cobas BV/CV Assay, a new PCR-based diagnostic test that has received the CE Mark for use in accepting countries. This assay is designed to streamline the diagnostic workflow for vaginitis by utilizing a single vaginal swab to rapidly and accurately detect the bacteria responsible for bacterial vaginosis and the yeast associated with candida vaginitis.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Roche (F. Hoffmann-La Roche Ltd.)
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • bioMerieux
  • Hologic
  • QIAGEN
  • Bio-Rad Laboratories
  • Danaher
  • Grifols S.A.
  • Seegene Inc.
  • Others

GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TYPE - MARKET ANALYSIS, 2019 - 2032

  • Polymerase Chain Reaction (PCR) Tests
  • Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
  • Others

GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

  • Infectious Disease Testing
  • Oncology Testing
  • Genetic & Mitochondrial Disease Testing
  • Others

GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USE - MARKET ANALYSIS, 2019 - 2032

  • Central and Reference Laboratories
  • Point-of-Care Settings
  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutes
  • Others

GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Nucleic Acid Amplification Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Nucleic Acid Amplification Testing Market Snippet by Type
    • 2.1.2. Nucleic Acid Amplification Testing Market Snippet by Application
    • 2.1.3. Nucleic Acid Amplification Testing Market Snippet by End-use
    • 2.1.4. Nucleic Acid Amplification Testing Market Snippet by Country
    • 2.1.5. Nucleic Acid Amplification Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Nucleic Acid Amplification Testing Key Market Trends

  • 3.1. Nucleic Acid Amplification Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Nucleic Acid Amplification Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Nucleic Acid Amplification Testing Market Opportunities
  • 3.4. Nucleic Acid Amplification Testing Market Future Trends

4. Nucleic Acid Amplification Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Nucleic Acid Amplification Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Nucleic Acid Amplification Testing Market Landscape

  • 6.1. Nucleic Acid Amplification Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Nucleic Acid Amplification Testing Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024&2032 (%)
    • 7.1.2. Polymerase Chain Reaction (PCR) Tests
    • 7.1.3. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
    • 7.1.4. Others

8. Nucleic Acid Amplification Testing Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024&2032 (%)
    • 8.1.2. Infectious Disease Testing
    • 8.1.3. Oncology Testing
    • 8.1.4. Genetic & Mitochondrial Disease Testing
    • 8.1.5. Others

9. Nucleic Acid Amplification Testing Market - By End-use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-use, 2024&2032 (%)
    • 9.1.2. Infectious Disease Testing
    • 9.1.3. Oncology Testing
    • 9.1.4. Genetic & Mitochondrial Disease Testing
    • 9.1.5. Others

10. Nucleic Acid Amplification Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Nucleic Acid Amplification Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.2.6. North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.2.8.5. Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Nucleic Acid Amplification Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.3.6. Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.7.5. Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.8.5. UK Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.9.5. France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.10.5. Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.11.5. Spain Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.14.5. Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.15.5. Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Nucleic Acid Amplification TestingKey Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.4.6. APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.7.5. China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.8.5. India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.9.5. Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.11.5. Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.14.3. PhilippinesMarket Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Nucleic Acid Amplification Testing Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.5.6. LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Nucleic Acid Amplification TestingKey Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 10.6.6. MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.8.5. UAE Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.9.5. Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)

11. Key Vendor Analysis- Nucleic Acid Amplification Testing Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Roche (F. Hoffmann-La Roche Ltd.)
    • 11.2.2. Abbott Laboratories
    • 11.2.3. Thermo Fisher Scientific Inc.
    • 11.2.4. bioMerieux
    • 11.2.5. Hologic
    • 11.2.6. QIAGEN
    • 11.2.7. Bio-Rad Laboratories
    • 11.2.8. Danaher
    • 11.2.9. Grifols S.A.
    • 11.2.10. Seegene Inc.
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us